Press Releases :: CohBar, Inc. (CWBR)

CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

The companies hosted a joint webcast on May 23, 2023, to discuss the transaction.

Morphogenesis Website

Access Webcast Replay

Feb 06, 2017 8:30am EST

CohBar Inc. Presentation Now Available for On-Demand Viewing

Feb 01, 2017 8:00am EST

CohBar Inc. to Webcast, Live, at VirtualInvestorConferences.com February 2

Jan 11, 2017 9:44am EST

CohBar, Inc. Announces Expiration of Warrants and Reports Aggregate Proceeds from Warrant Exercises

Jan 10, 2017 8:06pm EST

CohBar, Inc.’s CEO Simon Allen to Present at the 9th Annual Biotech Showcase in San Francisco

Dec 06, 2016 9:00am EST

CohBar, Inc. Continues Exploration of Mitochondrial Genome and Expansion of Its IP Portfolio with Filing of 29 New Provisional Patents

Nov 14, 2016 9:00am EST

CohBar, Inc. Announces Third Quarter 2016 Financial Results

Oct 18, 2016 9:00am EDT

CohBar, Inc.’s CEO Simon Allen to Present at BIO Investor Forum 2016

Oct 13, 2016 9:00am EDT

CohBar, Inc. Announces Discovery of New Peptides in the Mitochondrial Genome

Sep 30, 2016 9:00am EDT

CohBar Advances First-in-Class Mitochondria Based Therapeutic to IND-Enabling Activities

Aug 15, 2016 9:00am EDT

CohBar, Inc. Announces Second Quarter 2016 Financial Results